MPZ and Charcot-Marie-Tooth disease type 2: The MFN2 mutation accounted for 16% of the CMT2 patients in a Spanish cohort study, and 18% of CMT2 without MPZ and GJB1 mutations in French patients (Calvo et al.,2009; Casasnovas et al.,2010).